+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Marine Derived Drugs Market by Source, Drug Type, End-User - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 181 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 4904827
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Marine Derived Drugs Market grew from USD 4.10 billion in 2023 to USD 4.44 billion in 2024. It is expected to continue growing at a CAGR of 8.70%, reaching USD 7.36 billion by 2030.

Marine-derived drugs refer to pharmaceutical substances that are developed from compounds isolated from marine organisms. This unique sector is defined by its utilization of marine biodiversity, including organisms like sponges, corals, tunicates, and marine bacteria/algae, to discover bioactive compounds with therapeutic potential. The necessity of these drugs stems from their unique chemical structures and functionalities, which often offer novel mechanisms for treating diseases, especially against drug-resistant pathogens and for conditions such as cancer, inflammation, and infectious diseases. The application of marine-derived drugs spans across pharmaceuticals, nutraceuticals, and cosmeceuticals, addressing a broad range of end-uses from health supplements to dermatological products.

Market growth is significantly influenced by increased investment in marine biotechnology, advances in marine pharmacology technologies, and a rising demand for novel natural medicines. The discovery of previously unexamined marine areas thanks to deep-sea exploration technologies fuels the emergence of new drug candidates, providing substantial growth opportunities. Moreover, collaborations between research institutes and biotech firms are proving vital in harvesting marine compounds sustainably. However, challenges include the complexity and high cost associated with marine drug development, including extraction and synthesis processes, stringent regulatory frameworks, and the ecological concerns of marine resource utilization. Environmental shifts and limited knowledge about marine species biology may also impede sustainable exploration efforts.

Innovation is poised to thrive in areas such as the use of AI in drug discovery, the development of synthetic and biosynthetic methodologies to reproduce marine compounds, and sustainable aquaculture practices for marine species cultivation. Expansion into untapped geographical marine zones could provide additional drug discovery avenues. By addressing these challenges and exploring innovative strategies, businesses can enhance their market position, aligning ecological sustainability with commercial objectives. Understanding these dynamics is crucial for stakeholders to navigate this promising yet intricate market landscape effectively.

Understanding Market Dynamics in the Marine Derived Drugs Market

The Marine Derived Drugs Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Increasing prevalence of chronic diseases worldwide
    • Growing investments in marine biotechnologies by government and private authorities
  • Market Restraints
    • High cost of development of new drugs associated with marine sources
  • Market Opportunities
    • Increasing advances in extraction and synthesis technologies of marine derived drugs
    • Growing focus on expanding therapeutic potential of marine-derived drugs
  • Market Challenges
    • Environmental and ethical concerns with marine derived drugs

Exploring Porter’s Five Forces for the Marine Derived Drugs Market

Porter’s Five Forces framework further strengthens the insights of the Marine Derived Drugs Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Marine Derived Drugs Market

External macro-environmental factors deeply influence the performance of the Marine Derived Drugs Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Marine Derived Drugs Market

The Marine Derived Drugs Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Marine Derived Drugs Market

The Marine Derived Drugs Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Marine Derived Drugs Market

The Marine Derived Drugs Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Marine Derived Drugs Market, highlighting leading vendors and their innovative profiles. These include Aker BioMarine ASA, Aphios Corporation, Eisai Co., Ltd., Gimv NV, GlycoMar Limited, Marinova Pty Ltd., Nereus Pharmaceuticals, Inc., Perha Pharmaceuticals, Pfizer, Inc., Pharma Mar, S.A., TransAlgae, and Zelnova Zeltia.

Market Segmentation & Coverage

This research report categorizes the Marine Derived Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Source
    • Algae
    • Invertebrates
    • Microorganisms
  • Drug Type
    • Analgesics
    • Anti-coagulants
    • Anti-inflammatory
    • Anti-microbial
    • Anti-viral
    • Anticancer
  • End-User
    • Hospitals
    • Pharmaceutical & Biotechnology Companies
    • Research & Academic Institutions
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Marine Derived Drugs Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. High prevalence of unmet medical needs
5.1.1.2. Increasing initiatives for preserving marine biodiversity
5.1.1.3. Rising incidence of chronic ailments
5.1.2. Restraints
5.1.2.1. Complexity in drug development from marine sources due to environmental conditions and microorganisms residing in the marine animal
5.1.3. Opportunities
5.1.3.1. Innovation of pharmaceutical products
5.1.3.2. Advances in cancer therapy and immune signaling
5.1.3.3. Increase in pharmacokinetic research on marine-derived compounds
5.1.4. Challenges
5.1.4.1. Lack of awareness and social taboos commonly associated with advanced medications
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
6. Marine Derived Drugs Market, by Type
6.1. Introduction
6.2. Ether
6.3. Peptide
6.4. Phenol
6.5. Steroid
7. Marine Derived Drugs Market, by Source
7.1. Introduction
7.2. Algae
7.3. Invertebrates
7.4. Microorganisms
8. Marine Derived Drugs Market, by Mode of Delivery
8.1. Introduction
8.2. Anti-Cardiovascular
8.3. Anti-Inflammatory
8.4. Anti-Microbial
8.5. Anti-Tumor
8.6. Anti-Viral
9. Americas Marine Derived Drugs Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Marine Derived Drugs Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Marine Derived Drugs Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. Aker BioMarine ASA
13.1.3. Amicogen, Inc.
13.1.4. Amway Corporation
13.1.5. Aphios Corporation
13.1.6. BASF SE
13.1.7. BioMarin
13.1.8. Croda International PLC
13.1.9. Koninklijke DSM N.V.
13.1.10. Nordic Naturals
13.1.11. Pharma Marine AS
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
List of Figures
FIGURE 1. MARINE DERIVED DRUGS MARKET RESEARCH PROCESS
FIGURE 2. MARINE DERIVED DRUGS MARKET SIZE, 2022 VS 2030
FIGURE 3. MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
FIGURE 5. MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 6. MARINE DERIVED DRUGS MARKET DYNAMICS
FIGURE 7. MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2022 VS 2030 (%)
FIGURE 8. MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 9. MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2022 VS 2030 (%)
FIGURE 10. MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 11. MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2022 VS 2030 (%)
FIGURE 12. MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 14. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
FIGURE 16. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
FIGURE 21. MARINE DERIVED DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
FIGURE 22. MARINE DERIVED DRUGS MARKET SHARE, BY KEY PLAYER, 2022
List of Tables
TABLE 1. MARINE DERIVED DRUGS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
TABLE 3. MARINE DERIVED DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL MARINE DERIVED DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 6. MARINE DERIVED DRUGS MARKET SIZE, BY ETHER, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. MARINE DERIVED DRUGS MARKET SIZE, BY PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. MARINE DERIVED DRUGS MARKET SIZE, BY PHENOL, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. MARINE DERIVED DRUGS MARKET SIZE, BY STEROID, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 11. MARINE DERIVED DRUGS MARKET SIZE, BY ALGAE, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. MARINE DERIVED DRUGS MARKET SIZE, BY INVERTEBRATES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. MARINE DERIVED DRUGS MARKET SIZE, BY MICROORGANISMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 15. MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-CARDIOVASCULAR, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-INFLAMMATORY, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-MICROBIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-TUMOR, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. MARINE DERIVED DRUGS MARKET SIZE, BY ANTI-VIRAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 24. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 27. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 30. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 31. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 32. CANADA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 33. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 34. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 35. MEXICO MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 36. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES MARINE DERIVED DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 40. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 44. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 47. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 48. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 49. CHINA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 50. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 51. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 52. INDIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 53. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 56. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 58. JAPAN MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 59. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 62. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 65. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 68. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 71. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 74. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 75. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 76. THAILAND MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 77. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 80. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 84. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 85. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 86. DENMARK MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 87. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 88. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 89. EGYPT MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 90. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 91. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 92. FINLAND MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 93. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 94. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 95. FRANCE MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 96. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 97. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 98. GERMANY MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 99. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 102. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 103. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 104. ITALY MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 105. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 108. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 111. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 112. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 113. NORWAY MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 114. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 115. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 116. POLAND MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 117. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 118. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 119. QATAR MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 120. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 123. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 126. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 129. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 130. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 131. SPAIN MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 132. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 135. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 138. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 139. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 140. TURKEY MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 141. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 144. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY SOURCE, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM MARINE DERIVED DRUGS MARKET SIZE, BY MODE OF DELIVERY, 2018-2030 (USD MILLION)
TABLE 147. MARINE DERIVED DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
TABLE 148. MARINE DERIVED DRUGS MARKET SHARE, BY KEY PLAYER, 2022
TABLE 149. MARINE DERIVED DRUGS MARKET LICENSE & PRICING

Companies Mentioned

The leading players in the Marine Derived Drugs market, which are profiled in this report, include:
  • Aker BioMarine ASA
  • Aphios Corporation
  • Eisai Co., Ltd.
  • Gimv NV
  • GlycoMar Limited
  • Marinova Pty Ltd.
  • Nereus Pharmaceuticals, Inc.
  • Perha Pharmaceuticals
  • Pfizer, Inc.
  • Pharma Mar, S.A.
  • TransAlgae
  • Zelnova Zeltia

Methodology

Loading
LOADING...

Table Information